Phosphoramidite Market Report Provides Insights Into Market Evolution And Growth Prospects

Understanding the future trajectory of the phosphoramidite market reveals promising growth driven by advancements in biotechnology and pharmaceutical research. This sector is expanding due to increasing demand for DNA and RNA synthesis materials, coupled with evolving therapeutic and diagnostic applications. Let's explore the market's valuation trends, key players, driving forces, innovations, and the critical segments shaping this industry.

Phosphoramidite Market Size and Expected Expansion
The phosphoramidite market has witnessed solid growth recently, expanding from $1.07 billion in 2025 to an anticipated $1.15 billion in 2026, supported by a 7.1% compound annual growth rate (CAGR). This historical growth stems from heightened DNA sequencing activities, increased funding for academic research, greater utilization of synthetic nucleic acids, improvements in solid-phase synthesis methods, and growing demand in molecular diagnostics.

Download a free sample of the phosphoramidite market report:
https://thebusinessresearchcompany.com/sample_request?id=71215212&type=smp&name=Phosphoramidite%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR

Looking ahead, the market is forecast to continue its robust expansion, reaching $1.5 billion by 2030 with a CAGR of 6.9%. Several factors will contribute to this upward trend, including the rising development of RNA-based therapeutics, advancements in gene editing technologies, enhanced investment in pharmaceutical R&D, increasing requirements for custom oligonucleotides, and scaling of automated synthesis platforms. Key trends have emerged around greater demand for oligonucleotide synthesis materials, growth in gene therapy and RNA therapeutics, wider use in diagnostics and research, adoption of automated solid-phase synthesis, and a stronger focus on high-purity chemical inputs.

Leading Organizations Influencing the Phosphoramidite Market
The phosphoramidite industry is dominated by several prominent companies, such as Thermo Fisher Scientific Inc., Agilent Technologies Inc., Aragen Life Sciences, Twist Bioscience, Innovassynth Technologies (I) Ltd., Tokyo Chemical Industry Co. Ltd. (TCI), Aurigene Services, Eurofins Genomics, LGC Biosearch Technologies, Link Technologies Ltd., Creative Biolabs, Biosynth Carbosynth, TriLink BioTechnologies, ChemGenes Corporation, Berry & Associates Inc., Lumiprobe Corporation, Hongene Biotech Corporation, Carbolink India Pvt. Ltd., PolyOrg Inc., Glen Research, Gene Link Inc., and emp BIOTECH GmbH.

View the full phosphoramidite market report:
https://www.thebusinessresearchcompany.com/report/phosphoramidite-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR

A notable collaboration occurred in May 2023, when US-based Actylis partnered with India's Innovassynth to address vulnerabilities in the nucleic acid supply chain. This alliance aims to strengthen the phosphoramidite market by ensuring a reliable, transparent, and diversified supply of high-quality nucleosides and phosphoramidites for pharmaceutical and biotech applications. Innovassynth India specializes in manufacturing protected nucleosides, phosphoramidites, and reagents.

Emerging Trends Transforming the Phosphoramidite Industry
Key market players are heavily focused on advancing DNA synthesis technologies. One example is the use of convertible-preferred stock financing to accelerate the adoption of Gibson SOLA technology, which enables rapid DNA and mRNA synthesis. Convertible-preferred stock financing involves raising capital through preferred shares that can later convert into common shares.

In March 2025, Telesis Bio Inc., a US biotechnology firm, secured up to $21 million in new funding to fast-track the commercialization of its next-generation enzymatic DNA synthesis platform, Gibson SOLA. Supported by various strategic investors, this capital injection will help expand R&D and manufacturing capabilities, as well as broaden market access to rapid and customizable long-DNA synthesis. This proprietary enzymatic method promises quicker and more precise synthesis of lengthy DNA sequences, overcoming traditional limitations posed by phosphoramidite-based techniques.

Key Segments Defined in the Phosphoramidite Market Report
This report segments the phosphoramidite market as follows:

1) By Type:
- Deoxyribonucleic Acid (DNA) Phosphoramidites
- Ribonucleic Acid (RNA) Phosphoramidites
- Labeled Phosphoramidites
- Modifier Phosphoramidites
- Other Types

2) By Synthesis Method:
- H-Phosphonate Method
- Phosphoramidite Method
- Trivalent Phosphorus Compounds Method

3) By Application:
- Gene Synthesis
- DNA Sequencing
- DNA Amplification

4) By End-User:
- Academic Research
- Pharmaceutical Industry
- Biotechnology Industry

Further subcategories include:
- DNA Phosphoramidites: Standard, Degenerate, Methylated, Backbone-Modified
- RNA Phosphoramidites: Standard, 2'-O-Methyl, 2'-Fluoro, 2'-O-TBDMS Protected
- Labeled Phosphoramidites: Fluorescent, Biotin, Digoxigenin, Radioisotope
- Modifier Phosphoramidites: Amine-Modified, Thiol-Modified, Spacer, Azide-Modified
- Other Types: Chimeric, Phosphorothioate, PEGylated, Photo-Cleavable

This comprehensive segmentation allows for a detailed understanding of market dynamics and specialized areas of growth within the phosphoramidite sector.

What's included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.